Rapport Therapeutics, Inc. (RAPP)

NGM – Цена в реальном времени. Валюта: USD

40.06

+1.15 (2.96%)

При закрытии: Jun 26, 2026, 4:00 PM EDT

40.06

-0.00 (-0.00%)

После закрытия: Jun 26, 2026, 4:31 PM EDT

Обзор
Новости
График
Финансы
Дивиденды
Прогноз
Владельцы
Профиль

Rapport Therapeutics, Inc. (RAPP)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях

Rapport Therapeutics, Inc. (RAPP)

Rapport Therapeutics, Inc. (RAPP) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript

Rapport Therapeutics to Participate in the Jefferies Global Healthcare Conference and Goldman Sachs 47th Annual Global Healthcare Conference

Rapport Therapeutics, Inc. (RAPP) Reports Q1 Loss

Rapport Therapeutics Reports First Quarter 2026 Financials and Provides Business Update

MISE A DISPOSITION DU RAPPORT FINANCIER ANNUEL 2025

Rapport Therapeutics Presents RAP-219 Focal Onset Seizure Phase 2a Follow-up Period Results Demonstrating Sustained Seizure Reduction at the 2026 American Academy of Neurology Annual Meeting

Communiqué de mise à disposition du rapport financier annuel 2025

Видео

No Data

Пресс-релизы

Rapport Therapeutics Reports First Quarter 2026 Financials and Provides Business Update

MISE A DISPOSITION DU RAPPORT FINANCIER ANNUEL 2025

Rapport Therapeutics Presents RAP-219 Focal Onset Seizure Phase 2a Follow-up Period Results Demonstrating Sustained Seizure Reduction at the 2026 American Academy of Neurology Annual Meeting

Communiqué de mise à disposition du rapport financier annuel 2025

Search stocks

Rapport Therapeutics, Inc. (RAPP)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях

Rapport Therapeutics, Inc. (RAPP)

Rapport Therapeutics, Inc. (RAPP) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript

Rapport Therapeutics to Participate in the Jefferies Global Healthcare Conference and Goldman Sachs 47th Annual Global Healthcare Conference

Rapport Therapeutics, Inc. (RAPP) Reports Q1 Loss

Rapport Therapeutics Reports First Quarter 2026 Financials and Provides Business Update

MISE A DISPOSITION DU RAPPORT FINANCIER ANNUEL 2025

Rapport Therapeutics Presents RAP-219 Focal Onset Seizure Phase 2a Follow-up Period Results Demonstrating Sustained Seizure Reduction at the 2026 American Academy of Neurology Annual Meeting

Communiqué de mise à disposition du rapport financier annuel 2025

Видео

No Data

Пресс-релизы

Rapport Therapeutics Reports First Quarter 2026 Financials and Provides Business Update

MISE A DISPOSITION DU RAPPORT FINANCIER ANNUEL 2025

Rapport Therapeutics Presents RAP-219 Focal Onset Seizure Phase 2a Follow-up Period Results Demonstrating Sustained Seizure Reduction at the 2026 American Academy of Neurology Annual Meeting

Communiqué de mise à disposition du rapport financier annuel 2025